Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated:  12/31/1969
Wayne State University
mi
from
Detroit, MI
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated: 12/31/1969
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated:  12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated:  12/31/1969
Wake Forest University
mi
from
Charlotte, NC
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated: 12/31/1969
Wake Forest University
mi
from
Charlotte, NC
Click here to add this to my saved trials
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated:  12/31/1969
RTI International
mi
from
Durham, NC
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated: 12/31/1969
RTI International
mi
from
Durham, NC
Click here to add this to my saved trials
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated:  12/31/1969
Duke University
mi
from
Durham, NC
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Medical Center
mi
from
Cincinnati, OH
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve University, Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve University, Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated:  12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
mi
from
Providence, RI
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated: 12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
mi
from
Providence, RI
Click here to add this to my saved trials
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Early Diagnosis of Candidiasis in Premature Infants
Early Diagnosis of Nosocomial Candidiasis Study
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Palo Alto, CA
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated:  12/31/1969
University of Miami
mi
from
Miami, FL
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated: 12/31/1969
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated:  12/31/1969
Wayne State University
mi
from
Detroit, MI
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated: 12/31/1969
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated:  12/31/1969
Wake Forest University
mi
from
Charlotte, NC
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated: 12/31/1969
Wake Forest University
mi
from
Charlotte, NC
Click here to add this to my saved trials
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated:  12/31/1969
RTI International
mi
from
Durham, NC
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated: 12/31/1969
RTI International
mi
from
Durham, NC
Click here to add this to my saved trials
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated:  12/31/1969
Duke University
mi
from
Durham, NC
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Immunogenicity of PCV-7 Vaccine in VLBW Infants
Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Probiotic Supplement and Microbiome, Immune System and Metabolic Syndrome
Impact of a Probiotic Supplement on the Microbiome, Immune System, and Metabolic Syndrome
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Stanford, CA
Probiotic Supplement and Microbiome, Immune System and Metabolic Syndrome
Impact of a Probiotic Supplement on the Microbiome, Immune System, and Metabolic Syndrome
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated:  12/31/1969
Trius Study Site #011
mi
from
Dothan, AL
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated: 12/31/1969
Trius Study Site #011
mi
from
Dothan, AL
Click here to add this to my saved trials
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated:  12/31/1969
Trius Study site #001
mi
from
Chula Vista, CA
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated: 12/31/1969
Trius Study site #001
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated:  12/31/1969
Trius Study Site #009
mi
from
Long Beach, CA
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated: 12/31/1969
Trius Study Site #009
mi
from
Long Beach, CA
Click here to add this to my saved trials
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated:  12/31/1969
Trius Study site #002
mi
from
Oceanside, CA
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated: 12/31/1969
Trius Study site #002
mi
from
Oceanside, CA
Click here to add this to my saved trials
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated:  12/31/1969
Trius Study site #010
mi
from
Pasadena, CA
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated: 12/31/1969
Trius Study site #010
mi
from
Pasadena, CA
Click here to add this to my saved trials
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated:  12/31/1969
Trius Study site 007
mi
from
San Francisco, CA
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated: 12/31/1969
Trius Study site 007
mi
from
San Francisco, CA
Click here to add this to my saved trials
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated:  12/31/1969
Trius Study site 003
mi
from
San Jose, CA
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated: 12/31/1969
Trius Study site 003
mi
from
San Jose, CA
Click here to add this to my saved trials
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated:  12/31/1969
Trius Study site 004
mi
from
Columbus, GA
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated: 12/31/1969
Trius Study site 004
mi
from
Columbus, GA
Click here to add this to my saved trials
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated:  12/31/1969
Trius Study site #006
mi
from
Ludowici, GA
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated: 12/31/1969
Trius Study site #006
mi
from
Ludowici, GA
Click here to add this to my saved trials
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated:  12/31/1969
Trius Study site #005
mi
from
Savannah, GA
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated: 12/31/1969
Trius Study site #005
mi
from
Savannah, GA
Click here to add this to my saved trials
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated:  12/31/1969
Trius Study site #012
mi
from
Springfield, IL
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated: 12/31/1969
Trius Study site #012
mi
from
Springfield, IL
Click here to add this to my saved trials
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated:  12/31/1969
Trius study sie #008
mi
from
Detroit, MI
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status: Enrolling
Updated: 12/31/1969
Trius study sie #008
mi
from
Detroit, MI
Click here to add this to my saved trials
Centralized Reminder Recall - Flu RCT2
Centralized IIS-Based Reminder Recall to Increase Influenza Vaccination Rates in New York State - Second Trial in New York State
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Centralized Reminder Recall - Flu RCT2
Centralized IIS-Based Reminder Recall to Increase Influenza Vaccination Rates in New York State - Second Trial in New York State
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated:  12/31/1969
Ruane Clinical Research Group
mi
from
Los Angeles, CA
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated: 12/31/1969
Ruane Clinical Research Group
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated:  12/31/1969
Stanford Hospital and Clinics
mi
from
Palo Alto, CA
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated: 12/31/1969
Stanford Hospital and Clinics
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated:  12/31/1969
Inland Empire Liver Foundation
mi
from
Rialto, CA
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated: 12/31/1969
Inland Empire Liver Foundation
mi
from
Rialto, CA
Click here to add this to my saved trials
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente
mi
from
San Diego, CA
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated:  12/31/1969
University of Colorado Denver (Leprino Building)
mi
from
Aurora, CO
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver (Leprino Building)
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated:  12/31/1969
Orlando Immunology Center
mi
from
Orlando, FL
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated: 12/31/1969
Orlando Immunology Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated:  12/31/1969
Emory Hospital Midtown Infectious Disease Clinic
mi
from
Atlanta, GA
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated: 12/31/1969
Emory Hospital Midtown Infectious Disease Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated:  12/31/1969
Gastrointestinal Specialists of Georgia
mi
from
Marietta, GA
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated: 12/31/1969
Gastrointestinal Specialists of Georgia
mi
from
Marietta, GA
Click here to add this to my saved trials
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated:  12/31/1969
Saint Louis University, Gastroenterology & Hepatology, Clinical Research Unit
mi
from
Saint Louis, MO
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated: 12/31/1969
Saint Louis University, Gastroenterology & Hepatology, Clinical Research Unit
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated:  12/31/1969
NYU Langone Medical Center
mi
from
New York, NY
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated: 12/31/1969
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center & New York Presbyterian
mi
from
New York, NY
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center & New York Presbyterian
mi
from
New York, NY
Click here to add this to my saved trials
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated:  12/31/1969
Center for Liver Diseases, Oakland
mi
from
Pittsburgh, PA
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated: 12/31/1969
Center for Liver Diseases, Oakland
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated:  12/31/1969
University Gastroenterology
mi
from
Providence, RI
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated: 12/31/1969
University Gastroenterology
mi
from
Providence, RI
Click here to add this to my saved trials
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated:  12/31/1969
Gastro One
mi
from
Germantown, TN
Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
An Open-Label Study to Evaluate the Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Status: Enrolling
Updated: 12/31/1969
Gastro One
mi
from
Germantown, TN
Click here to add this to my saved trials